Skip to content

Expression of inflammatory markers in chronic dermatophytosis

An analytical study on the mRNA expression of inflammatory cytokines in chronic dermatophytosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/03/050254
Enrollment
60
Registered
2023-03-02
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B359- Dermatophytosis, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Yenepoya Medical College
Lead Sponsor
Dr Yashodhar P Bhandary
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Cases: Patients aged 18 and above visiting OPD of DVL with clinical diagnosis of chronic dermatophytosis Controls : Age and gender matched healthy volunteers who do not have dermatophytosis

Exclusion criteria

Exclusion criteria: For cases and controls : 1)Patients with inflammatory skin or systemic diseases including psoriasis, connective tissue diseases, diabetes, atopic disorders, immunocompromised status and women, who are pregnant or lactating or with other disorders as per judgement by investigators. 2)Patients who have used topical corticosteroids or any form of antifungals in the past 1 month.

Design outcomes

Primary

MeasureTime frame
This study will give an account of the various interleukins expressed in the skin in dermatophytosis.Timepoint: 1 year

Secondary

MeasureTime frame
This will help widen the knowledge about the immunological response seen in chronic dermatophytosis that may help in designing new interventions in relcalcitrant disease.Timepoint: 1 year

Countries

India

Contacts

Public ContactSwathi AR

Yenepoya Medical College Hospital

manjunath576117@gmail.com9845009976

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026